Kurma Partners - Aug 9, 2023 Form 3 Insider Report for IO Biotech, Inc. (IOBT)

Role: 10%+ Owner
Signature: Kurma Partners, by: /s/ Remi Droller, Managing Partner
Stock symbol: IOBT
Transactions as of: Aug 9, 2023
Transactions value $: $0
Form type: 3
Date filed: 8/21/2023, 03:40 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IOBT	Common Stock						4.35M	Aug 9, 2023	See Footnote	F1, F4
holding	IOBT	Common Stock						1.85M	Aug 9, 2023	See Footnote	F2, F4
holding	IOBT	Common Stock						623K	Aug 9, 2023	See Footnote	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IOBT	Warrants (Right to Buy)							Aug 9, 2023	Common Stock	4.35M	$2.47	See Footnote	F1, F4, F5
holding	IOBT	Warrants (Right to Buy)							Aug 9, 2023	Common Stock	813K	$2.47	See Footnote	F2, F4, F5
holding	IOBT	Warrants (Right to Buy)							Aug 9, 2023	Common Stock	274K	$2.47	See Footnote	F3, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities are held by Kurma Growth Opportunities Fund FPCI. Kurma Partners is the management company of Kurma Growth Opportunities Fund FPCI.
F2	The securities are held by Kurma Biofund III FPCI. Kurma Partners is the management company of Kurma Biofund III FPCI.
F3	The securities are held by SKCI FPCI. Kurma Partners is the management company of SKCI FPCI.
F4	The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
F5	These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023).